NCT01885585View on ClinicalTrials.gov

Eliquis Regulatory Post Marketing Surveillance (rPMS)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Venous Thromboembolism
Interventions
DRUG

Apixaban

Trial Locations (1)

110-744

Local Institution, Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01885585 - Eliquis Regulatory Post Marketing Surveillance (rPMS) | Biotech Hunter | Biotech Hunter